Hims & Hers Health, Inc.

Healthcare · Medical - Equipment & Services

Overall research band Very weak

Quality Weak

Valuation Very weak

Balance sheet Very weak

Market confirmation Very weak

One-minute company read

What this report can tell you now

What the company does

Hims & Hers Health, Inc. operates a digital health platform that connects individuals with licensed medical professionals for virtual consultations and ongoing care. The company offers a range of health and wellness solutions directly to consumers through its websites and mobile app, including recurring prescription medications and a variety of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its main product categories are general wellness, sexual health, skincare, and hair care, with specific offerings such as vitamin C, melatonin, biotin, collagen protein supplements, moisturizers, serums, face washes, condoms, climax delay sprays and wipes, vibrators, lubricants, specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Hims & Hers serves consumers seeking convenient access to health and wellness products and services, generating revenue through direct-to-consumer sales and wholesale partnerships.

The current research profile is Turnaround Candidate, with elevated leverage. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

No single strength should be treated as decisive without reviewing the underlying evidence and data status.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

Read the latest filing or company update.
Check the financial period behind each metric.
Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC9.8%Model input; read with the evidence status and period context.

Operating margin4.5%Model input; read with the evidence status and period context.

Revenue CAGR · 4 years71.4%Model input; read with the evidence status and period context.

FCF margin3.2%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.

Evidence detailSee exact inputs, source context, and model-aware metrics.

HistoryReview score and research changes over time.

MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.